NFKB1 and metabolic dysfunction-associated steatohepatitis: This condition is further exacerbated by the release of free fatty acids and pro-inflammatory cytokines from visceral fat, which promotes hepatic steatosis and NASH progression through activation of the NF-κB pathway and endoplasmic reticulum stress (11, 13).